Synthomer has seen its fair value estimate move from £1.47 to £1.28, while published price targets in recent months have sat around 92 GBp and 100 GBp. Analysts have kept ratings at neutral levels around these targets, which points to ongoing debate about how to balance valuation, execution risk and growth assumptions. As you read on, you will see how this evolving price target story can help you track the shifting analyst narrative around Synthomer. Analyst Price Targets don't always capture...

Synthomer PLC (SYHMY) delivers strong first-half results with all divisions growing, upgraded full-year guidance, and a clear path to faster deleveraging.

Synthomer (LON:SYNT) reported first-half 2026 revenue and earnings growth ahead of expectations, citing specialty-product growth, cost actions and its ability to respond to supply-chain disruptions. The chemicals group also raised its full-year outlook and said it expects improved cash generation an

Synthomer plc ( LON:SYNT ), might not be a large cap stock, but it received a lot of attention from a substantial price...

Synthomer (LON:SYNT) reported its 2025 full-year results, with management emphasizing margin improvement, positive free cash flow, and a refinancing that extends debt maturities to 2029. CEO Michael Willomeit said the company delivered performance “fully in line with our January 29 winter trading st

tinyBuild (LSE:TBLD) shares rose sharply after the video games publisher swung to a $5.6 million EBITDA profit last year from a $6.1 million loss in 2024. Revenue grew 17% to $35.5 million, with survival shooter Deadside a big part of that story. East Star Resources shares are also moving higher after the company signed a joint venture with Hong Kong Xinhai Mining to develop its Kazakhstan copper deposit. Xinhai funds the whole $65 million development cost, leaving East Star with a free 30% stake in the mine. Sancus Lending Group had the biggest move of the day after the property lender nearly doubled new loan originations to £212.5 million. Profit before tax hit £1.2 million, up from just £100,000 the year before. Synthomer (LSE:SYNT) bounced after the chemicals group confirmed it won't be issuing new shares to cut its debt. Refinancing talks with lenders are described as proceeding constructively, and its biggest shareholder KLK is said to be very supportive. Quantum Blockchain Technologies (AIM:QBT) is moving closer to recovering money from its Sipiem case, with an Italian court scheduling a property auction for May the 6th. The company has recovered €743,500 so far from a damages award worth over €6 million. Quadrise (AIM:QED) has appointed Michael Covington to its board as a non-executive director. He brings over 30 years of experience across energy and finance, and is expected to take over as audit committee chair in due course. Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Synthomer, the London-listed chemicals group, is exploring plans to raise tens of millions of pounds from a sale of new shares as it tries to fortify its balance sheet. Sky News has learnt that Synthomer, which has seen its stock crash by more than 60% over the last year, is working with bankers at JP Morgan on the prospective cash call. City sources said a deal was not certain to proceed but that if it did so it could seek to raise more than its entire current market capitalisation of just £90m.

JPMorgan’s decision to trim its Synthomer price target to £1.02 from £1.12, while keeping a Neutral rating, shifts the story around the shares without pushing you toward a clear bullish or bearish camp. The move suggests analysts are taking a more cautious view on what the stock might be worth, even though they still see the business as capable of supporting the new target under updated revenue assumptions. Stay with this article to see how you can keep on top of future changes in this...

Synthomer's stock price target has moved modestly, with analysts trimming their expectations from 112 GBp to 102 GBp. Despite this reduction, the fair value and risk profile remain steady. This suggests consensus that the company's core fundamentals are largely intact. Stay tuned to discover how you can keep informed as the narrative around Synthomer continues to evolve. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value...